NCT05971069View on ClinicalTrials.gov

Real-time Identification of the Aberrant Left Hepatic Arterial Territory in the Liver Using Near-infrared Fluorescence Imaging

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

December 17, 2021

Primary Completion Date

June 12, 2023

Study Completion Date

June 12, 2023

Conditions
Stomach Neoplasm
Interventions
PROCEDURE

Group1

Entire fluorescence defect on the Lt. lobe of liver → Preservation of the aberrant left hepatic artery

PROCEDURE

Group2

Partial fluorecence defect on the Lt. lobe of liver → Ligation of the aberrant left hepatic artery

PROCEDURE

Group3

No fluorescence defect on the Lt. lobe of liver → Ligation of the aberrant left hepatic artery

Trial Locations (1)

Unknown

GangnamSeverance Hospital, Seoul

All Listed Sponsors
lead

Gangnam Severance Hospital

OTHER

NCT05971069 - Real-time Identification of the Aberrant Left Hepatic Arterial Territory in the Liver Using Near-infrared Fluorescence Imaging | Biotech Hunter | Biotech Hunter